» Articles » PMID: 29686832

Patterns and Predictors of Depression Treatment Among Older Adults with Parkinson's Disease and Depression in Ambulatory Care Settings in the United States

Overview
Journal Parkinsons Dis
Publisher Wiley
Date 2018 Apr 25
PMID 29686832
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Little is known regarding depression treatment patterns and predictors among older adults with comorbid Parkinson's disease and depression (dPD) in the United States (US). The objective of this study was to assess the patterns and predictors of depression treatment among older adults with dPD in the US. We adopted a cross-sectional study design by pooling multiple-year data (2005-2011) from the National Ambulatory Medical Care Survey (NAMCS) and the outpatient department of the National Hospital Ambulatory Medical Care Survey (NHAMCS). The final study sample consisted of visits by older adults with dPD. Depression treatment was defined as antidepressant use with or without psychotherapy. To identify predictors of depression treatment, multivariate logistic regression analysis was conducted adjusting for predisposing, enabling, and need factors. Individuals with dPD and polypharmacy were 74% more likely to receive depression treatment (odds ratio = 1.743, 95% CI 1.376-2.209), while dPD subjects with comorbid chronic conditions were 44% less likely (odds ratio = 0.559, 95% CI 0.396-0.790) to receive depression treatment. Approximately six out of ten older adults with PD and depression received depression treatment. Treatment options for dPD are underutilized in routine clinical practice, and further research should explore how overall medical complexity presents a barrier to depression treatment.

Citing Articles

Examining racial disparity in psychotic disorders related ambulatory care visits: an observational study using national ambulatory medical care survey 2010-2015.

Bazargan-Hejazi S, Shirazi A, Hampton D, Pan D, Askharinam D, Shaheen M BMC Psychiatry. 2023; 23(1):601.

PMID: 37592201 PMC: 10436449. DOI: 10.1186/s12888-023-05095-y.


Efficacy of non-pharmacological interventions for depression in individuals with Parkinson's disease: A systematic review and network meta-analysis.

Wang Y, Sun X, Li F, Li Q, Jin Y Front Aging Neurosci. 2022; 14:1050715.

PMID: 36438007 PMC: 9691406. DOI: 10.3389/fnagi.2022.1050715.


Exploring Treatment for Depression in Parkinson's Patients: A Cross-Sectional Analysis.

DeMarco E, Al-Hammadi N, Hinyard L Int J Environ Res Public Health. 2021; 18(16).

PMID: 34444343 PMC: 8392211. DOI: 10.3390/ijerph18168596.


Microglial Phagocytosis of Neurons: Diminishing Neuronal Loss in Traumatic, Infectious, Inflammatory, and Autoimmune CNS Disorders.

Yanuck S Front Psychiatry. 2019; 10:712.

PMID: 31632307 PMC: 6786049. DOI: 10.3389/fpsyt.2019.00712.

References
1.
Miller I, Cronin-Golomb A . Gender differences in Parkinson's disease: clinical characteristics and cognition. Mov Disord. 2010; 25(16):2695-703. PMC: 3003756. DOI: 10.1002/mds.23388. View

2.
Menza M, Mark M . Parkinson's disease and depression: the relationship to disability and personality. J Neuropsychiatry Clin Neurosci. 1994; 6(2):165-9. DOI: 10.1176/jnp.6.2.165. View

3.
Ehmann T, Beninger R, Gawel M, Riopelle R . Depressive symptoms in Parkinson's disease: a comparison with disabled control subjects. J Geriatr Psychiatry Neurol. 1990; 3(1):3-9. DOI: 10.1177/089198879000300102. View

4.
Nazem S, Siderowf A, Duda J, Brown G, Ten Have T, Stern M . Suicidal and death ideation in Parkinson's disease. Mov Disord. 2008; 23(11):1573-9. PMC: 2635951. DOI: 10.1002/mds.22130. View

5.
Althaus A, Arranz Becker O, Spottke A, Dengler R, Schneider F, Kloss M . Frequency and treatment of depressive symptoms in a Parkinson's disease registry. Parkinsonism Relat Disord. 2008; 14(8):626-32. DOI: 10.1016/j.parkreldis.2008.01.016. View